Key statistics
On Tuesday, Travere Therapeutics Inc (TVTX:NMQ) closed at 28.75, -31.76% below its 52-week high of 42.13, set on Dec 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 27.83 |
|---|---|
| High | 28.85 |
| Low | 27.01 |
| Bid | 27.90 |
| Offer | 32.00 |
| Previous close | 27.82 |
| Average volume | 1.42m |
|---|---|
| Shares outstanding | 89.47m |
| Free float | 84.04m |
| P/E (TTM) | -- |
| Market cap | 2.49bn USD |
| EPS (TTM) | -1.08 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
- Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Travere Therapeutics to Participate at Upcoming Investor Conferences
- Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
